Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Migraine Disorders"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Migraine+Disorders%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=Sumatriptan&type=AllFields
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Migraine+Disorders%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=Sumatriptan&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Migraine+Disorders%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=Sumatriptan&type=AllFields
PubPharm (30)
1
Magnesium Versus Prochlorperazine Versus Metoclopramide for Migraines : A Randomized, Placebo-Controlled, Double-Blind Study of the Effects of Magnesium Compared to Conventional Therapy on Acute Migraine
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
2
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents : A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
3
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg for the Treatment of Acute Migraine in Sumatriptan Non-Responders
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029) : A Randomized, Placebo-Controlled, Parallel-Groups, Outpatient Study to Compare the Efficacy and Safety of MK0462 5 mg p.o. and Sumatriptan 50 mg p.o. for the Acute Treatment of Migraine
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) : A Randomized, Placebo-Controlled, Parallel-Groups, Outpatient Study to Examine the Safety, Tolerability, and Efficacy of Single Oral Doses of MK0462 5 mg, MK0462 10 mg, and Sumatriptan 100 mg for Acute Treatment of Migraine
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks : A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Efficacy and Safety of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks.
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
7
Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study : A Multicentre, Double Blind, Double Dummy, Parallel Group, Placebo Controlled, Study of Two Dose Levels of Oral Eletriptan and Two Dose Levels Oral Sumatriptan Given for the Acute Treatment of Migraine(With and Without Aura).
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
8
Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo : A Multicenter, Double-blind, Placebo Controlled, Parallel Group, Study of Two Dose Levels of Oral Eletriptan and Two Dose Levels of of Oral Sumatriptan Given for the Acute Treatment of Migraine
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
9
Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan : A Multicenter, Double - Blind, Randomized, Placebo - Controlled Parallel Group Study of the Efficacy and Safety of Oral Eletriptan (40 and 80mg) Given for the Treatment of Acute Migraine in Subjects Discontinued From Oral Sumatriptan
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
10
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan : Imigran STATdose - Japan Clinical Experience Study for Self-injection
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Migraine Disorders
Filter aufheben
Thema: Phase: Phase 3
Medienart
30
Aufsätze
30
E-Artikel
30
E-Ressourcen
Zeitschriftentitel
30
ClinicalTrials.gov
Thema
30
610
Migraine Disorders
Phase: Phase 3
30
Study Type: Interventional
28
Recruitment Status: Completed
12
Medical Condition: Migraine Disorders
6
Headache
3
Medical Condition: Migraine Headache
3
Medical Condition: Migraine With or Without Aura
1
Cluster Headache
1
Dysmenorrhea
1
Medical Condition: Acute Migraine
1
Medical Condition: Migraine
1
Medical Condition: Migraine Disorders, Migraine
1
Medical Condition: Migraine Disorders, Migraine...
1
Medical Condition: Migraine Headaches
1
Medical Condition: Migraine With Aura, Migraine...
1
Medical Condition: Migraine in Adults
1
Medical Condition: Migraine, Headaches
1
Medical Condition: Migraine, Migraine Disorders
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
9
2020-
20
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
30
Englisch
Haven't found what you're looking for?
Wird geladen...